Search DrRajHealth

Saturday, April 22, 2017

New cells found in the retina, paving way for jet lag therapy

The cells of interest in this article express melanopsin receptors. Melanospin receptors detect blue wavelength light (same as the blue sky) and communicate directly to the SCN where it promotes increase in neurohormones such as dopamine, histamine, serotonin and vasopressin which all serve to promote wakefulness and to suppress sleep. Devices having LCD/LED screens (smartphones, tablets, monitors/TVs) emit an intense amount of blue wavelength light. The effect of such blue light exposure lasts 1-3 hours and subsequently the resultant sleep may be unrefreshing. So, in order to prevent sleep disruption, avoid such devices one hour prior to bedtime and dim/turn off other ambient light. http://ift.tt/1VMjaZw
from Rajesh Harrykissoon, MD

Atrial fibrillation patients may safely discontinue blood thinners after successful ablation

Discuss with your doctor. Bear in mind that atrial fibrillation is eight times more common in those with untreated sleep apnea than in those whose sleep apnea are treated. I you have atrial fibrillation consider a sleep study evaluation. Call our office for an evaluation. http://ift.tt/1VMjaZw
from Rajesh Harrykissoon, MD

Sinus surgery: Types, uses, and recovery

http://ift.tt/1VMjaZw
from Rajesh Harrykissoon, MD

Monday, April 10, 2017

57% of hospital executives rank improving ambulatory access as No. 1 concern

We have a lot of data which indicates it is really not an access issues in metroplex settings (access is more of a factor in rural settings). But, rather, it is an issue of utilization. We can place a clinic on the corner of every block in American and it will not increase utilization. The barrier to healthcare utilization is not an issue of geographic distance, but rather psychological distance. We can place a clinic in everyone's back yard, but psychologically that clinic might as well be on Mars. http://ift.tt/1VMjaZw
from Rajesh Harrykissoon, MD

Sunday, April 9, 2017

New Texas A&M lab gives health research a home

Fantastic new facility for human subject research. I've been working with this team for COPD and obstructive sleep apnea research for some years now with the objective of understanding how to improve quality-of-life and longevity. We are also recruiting patients with dementia and heart failure. We are about to release some amazing findings regarding COPD and muscle mass which is new and bucks the existing science. Enrollment screening for my interested patients is performed through my office. http://ift.tt/1VMjaZw
from Rajesh Harrykissoon, MD

Saturday, April 8, 2017

Trial of new triple inhaler shows 20% reduction in COPD flare-ups

We don't have a "tripple inhaler" on the market yet. But, many with COPD are on these classes of medications through current available options. These maintenance medications are not fast-acting, that is, you may not feel much of a difference today versus tomorrow with use, but they work to stabilize lung function and symptoms over the long term. This means you have to stick with them and compliantly use as prescribed to realize benefit. http://ift.tt/1VMjaZw
from Rajesh Harrykissoon, MD

Saturday, March 18, 2017

Paroxysmal atrial fibrillation: Causes, symptoms, and treatment

If you have atrial fibrillation, consider an evaluation of and treatment for sleep apnea. If your sleep apnea remains untreated subsequent to chemical or electrical cardioversion back to a normal rhythm, you are twice as likely to revert back into atrial fibrillation within one year according to a study. Call our office to schedule an evaluation. http://ift.tt/1VMjaZw
from Rajesh Harrykissoon, MD